Florida has been at the forefront of some very interesting healthcare mergers and acquisitions activity in the past year, including an influx of private equity, payor acquisition of provider groups, and consistent growth in not-for-profit vertical integration acquisitions. However, waves of reform are underway. If the Florida House gets its way, the pace of healthcare transactions in Florida may hit a speed bump.

The Florida House’s bipartisan momentum takes direct aim to slow provider consolidation in the State. In a striking video, the Florida House promises the 2019 legislative session will bring “more affordab[ility], more choices, more practitioners, more access, more quality, and more value” to the State’s health care market. In the video, the Florida House promises to end “government protection for hospital monopolies” and increase “enforcement against providers who violate antitrust laws.”

On April 11, 2019, the Florida House demonstrated its palpable commitment to these values by unanimously voting to pass Florida House Bill 1243 (“HB 1243” or “Bill”), sponsored by Rep. Colleen Burton (R). The Bill’s unanimous passage, only a month after being introduced, sends a strong signal that the Florida legislature is committed to ensuring antitrust law is followed and enforced in Florida hospital physician transactions.

If enacted into law, HB 1243 would require each party of any transaction involving a group practice, hospital, or hospital system that results in a “material change”[i] to another group practice of four or more physicians, the group practice, hospital, or hospital system to provide written notice to the Florida Office of Attorney General (“OAG”) at least 90 days before the effective date of such a transaction. A party’s failure to provide proper written notice would subject such entity to potential civil penalties of up to $500,000.00.

Additionally, in counties where there is only one entity contracting with or employing any category of medical specialists, such entity’s restrictive covenants would be void and unenforceable until there is new market entry by a competitor entity for at least three years.[ii]

HB1243 is designed to provide the Florida OAG with an opportunity to scrutinize hospital and group practice health care transactions of all sizes, including transactions that might not otherwise have required a federal pre-merger notification, filing, and review under the Federal Hart-Scott-Rodino Act (“HSR”).

Under HSR, parties entering into certain multi-million dollar transactions must file a notification and report form with the Federal Trade Commission and Assistant Attorney General of the Department of Justice, and wait a certain period (typically, 30 days) during which time the regulatory agencies may request further information to help them assess whether the proposed transaction violates the antitrust laws of the United States or could cause an anti-competitive effect in the parties’ markets. HB1243 would impose reporting and notification requirements on parties that would otherwise not have been affected by HSR and force a longer waiting period (90 days) upon parties that will simultaneously be required under federal law to file notice and reporting under HSR.

If enacted into law, HB 1243 will significantly affect all parties contemplating entering into health care transactions in Florida and may influence potential health care investor interest in the State of Florida.  Businesses contemplating entering into a health care transaction in Florida, will need to consider whether to expedite acquisitions, sales, and physician exit strategies before the Bill’s likely chilling effect on investor interest and unavoidable pre-transaction waiting period. While the Bill may not pass before the legislative session adjourns (Friday, May 3, 2019), the House’s commitment to health care transformation cannot be understated.

Reprinted by permission of The Florida Bar Health Law Updates.


[i] “Material change” is defined as: “(i) a merger, consolidation, or affiliation; (ii) the employment of all or substantially all of the physicians of a group practice; or (iii) the acquisition of all or substantially all of: (a) the properties and assets of a group practice; (b) the capital stock, membership interests, or other equity interests of a group practice; or (c) one or more insolvent group practices.”

[ii] Specifically, restrictive covenants entered into with physicians who practice a medical specialty in a county where one entity employs or contracts with, either directly or through related or affiliated entities, all restrictive covenants entered into with physicians who practice such specialty in that county would be void and unenforceable until three years after another entity enters the market and begins offering the medical specialty to the patients of that county.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.